Sutro Biopharma Inc (NASDAQ: STRO): The Best-Of-Breed For Investing?
Currently, there are 82.53M common shares owned by the public and among those 76.02M shares have been available to trade. The company’s stock has a 5-day price change of 21.43% and -63.58% over the past three months. STRO shares are trading -60.61% year to date (YTD), with the 12-month market performance down to -80.77% lower. […]
Sutro Biopharma Inc (NASDAQ: STRO): Stock That Needs Special Handling
Currently, there are 82.40M common shares owned by the public and among those 74.42M shares have been available to trade. The company’s stock has a 5-day price change of -45.99% and -65.53% over the past three months. STRO shares are trading -55.97% year to date (YTD), with the 12-month market performance down to -81.71% lower. […]